MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-13-2026
Harvard Bioscience Total Non Current Liabilities 2011-2026 | HBIO
Annual Total Non Current Liabilities Harvard Bioscience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 58.5 M | 57.9 M | 64.4 M | 14.4 M | 21 M | 23.2 M | 22.3 M | 24.9 M | 19.4 M | 21.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 64.4 M | 14.4 M | 32.8 M |
Total Non Current Liabilities of other stocks in the Medical instruments industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
12.9 M | - | - | $ 810 M |  USA |
 |
Milestone Scientific
MLSS
|
1.4 M | $ 0.32 | 1.78 % | $ 26.3 M | USA |
 |
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | USA |
 |
Alcon
ALC
|
6.05 B | $ 76.12 | 0.44 % | $ 40.4 B |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
11.2 M | $ 11.18 | 1.73 % | $ 27.1 M | USA |
 |
STERIS plc
STE
|
1.53 B | $ 222.27 | 0.23 % | $ 21.9 B | USA |
 |
iRhythm Technologies
IRTC
|
119 M | $ 126.75 | 3.6 % | $ 4.06 B | USA |
 |
The Cooper Companies
COO
|
1.54 B | $ 64.56 | 0.22 % | $ 12.9 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
30.2 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
1.16 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
74.1 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.99 B | - | -0.05 % | $ 10.3 B | USA |
 |
Repro Med Systems
KRMD
|
239 K | $ 4.06 | 2.53 % | $ 188 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
421 M | - | -0.02 % | $ 16.3 B | USA |
 |
Microbot Medical
MBOT
|
760 K | $ 2.17 | -1.36 % | $ 99.4 M |  Israel |
 |
Haemonetics Corporation
HAE
|
405 M | $ 61.14 | 1.93 % | $ 3.08 B | USA |
 |
electroCore
ECOR
|
1.42 M | $ 6.12 | -0.89 % | $ 51.9 K | USA |
 |
ICU Medical
ICUI
|
66.7 M | $ 123.04 | -1.43 % | $ 3.03 B | USA |
 |
Envista Holdings Corporation
NVST
|
1.91 B | $ 26.8 | 0.04 % | $ 4.5 B | USA |
 |
Isoray
ISR
|
621 K | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
418 M | $ 474.78 | -1.54 % | $ 169 B | USA |
 |
Glaukos Corporation
GKOS
|
87.4 M | $ 122.09 | 0.35 % | $ 5.91 B | USA |
 |
Masimo Corporation
MASI
|
56 M | $ 178.62 | -0.01 % | $ 9.52 B | USA |
 |
InfuSystem Holdings
INFU
|
35 M | $ 10.87 | 5.33 % | $ 224 M | USA |
 |
Teleflex Incorporated
TFX
|
2.77 B | $ 136.17 | -0.29 % | $ 6.08 B | USA |
 |
Merit Medical Systems
MMSI
|
626 M | $ 67.44 | -1.66 % | $ 3.99 B | USA |
 |
Utah Medical Products
UTMD
|
5.25 M | $ 67.69 | 0.77 % | $ 219 M | USA |
 |
Pulse Biosciences
PLSE
|
6.72 M | $ 22.92 | -0.43 % | $ 1.54 B | USA |
 |
West Pharmaceutical Services
WST
|
427 M | $ 302.34 | -1.16 % | $ 21.9 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
2.54 B | $ 11.88 | -0.29 % | $ 2.37 B | USA |
 |
Retractable Technologies
RVP
|
2.38 M | $ 0.64 | -2.14 % | $ 19.2 M | USA |
 |
Pro-Dex
PDEX
|
9.93 M | $ 51.58 | -1.0 % | $ 170 M | USA |
 |
LeMaitre Vascular
LMAT
|
19.3 M | $ 115.33 | 1.66 % | $ 2.61 B | USA |
 |
Predictive Oncology
POAI
|
236 K | - | - | $ 31.1 M | USA |
 |
STAAR Surgical Company
STAA
|
12.5 M | $ 26.33 | 2.57 % | $ 1.31 B | USA |
 |
BioLife Solutions
BLFS
|
41.7 M | $ 21.55 | 0.8 % | $ 993 M | USA |
 |
Stereotaxis
STXS
|
1.65 M | $ 1.94 | - | $ 176 M | USA |
 |
Baxter International
BAX
|
7.05 B | $ 18.25 | 0.5 % | $ 9.36 B | USA |
 |
ResMed
RMD
|
1.05 B | $ 221.51 | 0.81 % | $ 32.4 B | USA |
 |
AtriCure
ATRC
|
261 M | $ 29.3 | 0.07 % | $ 1.4 B | USA |
 |
NeuroMetrix
NURO
|
917 K | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
148 M | $ 11.13 | 0.27 % | $ 455 M | USA |
 |
Becton, Dickinson and Company
BDX
|
25 B | $ 150.96 | -0.76 % | $ 43.4 B | USA |
 |
Nephros
NEPH
|
1.61 M | $ 2.98 | 3.83 % | $ 31 M | USA |
 |
OraSure Technologies
OSUR
|
22.5 M | $ 2.96 | -1.5 % | $ 218 M | USA |
 |
Repligen Corporation
RGEN
|
701 M | $ 118.28 | 0.58 % | $ 6.59 M | USA |